Over 10 years relative median survival in MM patients ≤ 65 years with VGPR or better on 1st line treatment. Population-based data on patients diagnosed 2008-2018 from the Swedish Myeloma Registry
We present data showing improvement in response on treatment and in survival in Swedish MM patients since the forming of the national Swedish Myeloma Registry (SMR).
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Cecilie Hveding Blimark, Anna Genell, Johan Lund, Hareth Nahi, Kristina Carlson, Karin Forsberg, Gunnar Juliusson, Birgitta Lauri, Olle Linder, Signe Danielsson, Ronald Svensson, Ljupco Vesskovski, Dorota Knut-Bojanowska, Ingemar Turesson Source Type: research